The hire that unblocks everything else
A non-physician founder cannot launch a telehealth brand without a physician attached to the structure. In most states the clinical entity must be physician-owned, the protocols must carry a physician's sign-off, and the quality of oversight is what regulators, processors, and pharmacy partners all probe first. The medical director is therefore not a compliance accessory. They are the load-bearing wall of the MSO-friendly PC model, and hiring one is usually the critical path item between incorporation and first patient.
The failure mode is hiring for signature availability instead of clinical partnership. A rubber stamp gets you launched and then gets you investigated. The guide below is how to find someone real, pay them defensibly, and know the difference in one interview.
Where to find one
| Channel | Typical cost | Speed | Tradeoff |
|---|---|---|---|
| Placement services | From ~$799/month, often bundled with entity setup support | 1-4 weeks | Fast and packaged; you must still vet independence and time commitment yourself |
| Physician job boards and locum networks | Market rates you negotiate | 2-6 weeks | More vetting work, more control over fit |
| Referrals from pharmacy partners, platforms, healthcare counsel | Sourcing is free | Varies | Strongest signal, smallest pool |
| Clinician network vendors | Bundled into service fees | Days | Convenient, but oversight is tied to that vendor's model |
Placement services are the reason the "from $799 per month" figure circulates: they package a licensed physician willing to serve as medical director with the paperwork to attach them to your PC. That is a legitimate starting point for a single-state bootstrap. The caution is that the same convenience attracts physicians collecting directorships in volume, which is exactly the profile you are trying to screen out below.
Referrals deserve more effort than founders give them. Your compounding pharmacy, your platform, and your healthcare attorney each watch dozens of programs operate and know which directors actually engage. One warm introduction from that vantage point beats fifty cold applications.
How to pay: three models and one rule
Flat monthly retainer. The default for early DTC programs: a fixed fee covering protocol ownership, a defined block of oversight hours, chart audits, and availability for escalations. Entry pricing starts near that $799 figure through services; expect the number to climb as states, volume, and program complexity grow. Put the scope in writing: hours, response times, audit cadence, covered states.
Hourly review. Pays for protocol builds, chart audits, and consult time at an agreed rate. Works for pre-launch phases and very low volume, but becomes an incentive problem at scale, because the person responsible for quality is metered by the hour.
Retainer plus equity blend. A small advisory equity grant, typically a fraction of a percent vesting over a few years, on top of cash. Useful for making a genuinely engaged director think like an owner. Never use equity to replace cash for clinical duties.
The rule over all three: compensation must be fair market value for documented services, and it can never key to prescription volume, approval rates, or revenue. Percentage-of-revenue deals with the physician who controls prescribing walk straight into kickback and fee-splitting exposure. Pay for time, expertise, and accountability, and document what was delivered. This is also where good tooling earns its keep, a director who can see queues, protocols, and audit trails in one console does more oversight in two hours than an emailed spreadsheet allows in ten.
The ten interview questions
- Which states hold your active licenses today, and what is your plan for the states on our 12-month map?
- How many programs do you currently serve as medical director, and what does a typical week for ours look like?
- Walk me through how you would build or pressure-test our protocol for our lead condition.
- What would you audit monthly to satisfy yourself that asynchronous visits are safe?
- How do you think about corporate practice of medicine in our target states, and where do founders get it wrong?
- What would make you refuse to sign off on a protocol, a marketing claim, or a formulary addition?
- How do you want adverse events escalated to you, and inside what timeframe?
- What malpractice coverage do you carry, and what do you expect ours to cover?
- Have you worked inside an MSO-PC structure before, and what broke?
- What would make you resign?
The last one is not theater. A director with no resignation conditions has no standards you can rely on, and the answer tells you exactly where their line is before you ever test it. Strong candidates answer questions three through seven with specifics and usually push back on something in your current plan during the interview. That pushback is the product you are buying; the wider case for it is in clinical governance as a growth asset.
Red flags that end the conversation
Rubber-stamp availability. Instantly ready to sign, no questions about your protocols, patient population, or clinical standards. Enthusiasm without diligence is the whole risk in one sentence.
No state coverage plan. Licensed in two states, vague about the rest, no answer for how coverage scales with your map.
CPOM ignorance. Cannot explain corporate practice of medicine or their role in your entity structure. This person is signing legal documents whose meaning they do not know.
Directorship collecting. Serving many programs simultaneously with no credible accounting of hours. Regulators notice the same signature on a dozen aggressive brands.
Comp requests tied to volume. Any ask that links their pay to scripts, approvals, or revenue is them proposing your future enforcement action.
From one director to a board
One strong director carries a single-vertical program a long way. Add structure when the facts change: a second clinical vertical outside their specialty, controlled substances or lab-heavy protocols, entering a scrutinized category, or scale that turns oversight into a team function rather than a person. The next layer is a small clinical advisory board that adds specialty depth and credibility without replacing operational oversight, we covered the design in building a clinical advisory board. Whether your reviewing clinicians come from a network or your own hires shapes this too; the tradeoffs live in provider network vs your own clinicians.
FAQ
How much does a medical director for a telehealth startup cost? Placement services advertise medical directors from about $799 per month for entry-level, single-state arrangements, and costs rise with state coverage, program complexity, and patient volume. Compensation must be fair market value for documented services and can never be tied to prescription volume or revenue.
What does a telehealth medical director actually do? They own the clinical protocols, provide the physician oversight your entity structure requires, audit visit and chart quality, handle escalations and adverse events, and carry accountability with state boards. In MSO-PC structures they are often the physician owner of the professional corporation.
How do I know if a medical director candidate is a rubber stamp? They accept without reviewing your protocols, cannot describe what they would audit monthly, hold directorships at many programs at once, or are open to compensation tied to approvals or revenue. A real candidate asks hard questions about your patient population and pushes back on something before signing.
When should a telehealth startup add a clinical advisory board? When you add a second clinical vertical, enter lab-heavy or controlled-substance territory, or reach a scale where oversight needs specialty depth one director cannot cover. The board adds expertise and credibility; it does not replace the operational medical director role.